Browse every startup, VC firm, and investor tracked on DevCuration. 5,982 companies, sorted alphabetically.
Developing broad-spectrum antiviral preventive medicines for respiratory viruses.
Document intelligence for healthcare workflows
U.S.-focused continuation of GGV Capital with ~$5B AUM; 32 IPOs cleared; cloud, enterprise SaaS, consumer platforms, cybersecurity across U.S., Israel, Europe, Latin America
Explainable AI agents for regulated industries (insurance, finance, travel): customer support, claims intake, back office; pricing on resolved work; Phoenix Insurance customer-investor
All-in-one workspace for teams
AI mobility platform for traffic management: MobilityOS, edge AI, radar, computer vision, V2X retrofit on existing signals in <2 hours; 40+ US states deployed
Virtual nutrition care company providing insurance-covered access to registered dietitians focused on chronic disease and metabolic health.
Middle-market infrastructure PE focused on data centers and community solar (DartPoints, UGE International); Fund I $565M (2022), Fund II $1.45B
AI-powered wholesale insurance brokerage focused on the excess and surplus insurance market for complex commercial risks.
A health data infrastructure company that helps patients aggregate medical records and contribute anonymized data for medical research.
Industrial AI predictive maintenance company
Toronto-based alternative protein manufacturing technology company
Agentic Commerce Platform for consumer brands
AI agents on top of accounting, billing, data warehouses, spreadsheets with audit trails for explainable enterprise finance
Clinical-stage biotechnology company developing neuroprotective therapies targeting axon degeneration and neuroimmune dysfunction.
AI-powered animation production platform (Showcraft) for episodic content, films, and narrative arcs from existing IP
Nuro develops AI-powered autonomous vehicle infrastructure for logistics, commercial fleets, and consumer transportation systems.
Develops permanent low-emissivity and solar-control coatings for glass and lightweight polymer substrates.
A clinical-stage biotechnology company focused on acquiring and advancing rare disease therapies that have been deprioritized by larger pharmaceutical companies.